Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-25-113538

Chief Medical Officer sold 4,425 shares at an average $13.30 ($58,842)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kerr Douglas Chief Medical Officer 2025-09-04 Sale 10b5-1 −3,552 $13.27 $47,135 89,263 D
Kerr Douglas Chief Medical Officer 2025-09-05 Sale 10b5-1 −873 $13.41 $11,707 88,390 D
Open-market sales · 4,425 sh · avg $13.30 · $58,842
Loading xslF345X05/ownership.xml…